KEY FEATURES
| Full Name | Colony Stimulating Factor 3, Granulocyte |
|---|---|
| Synonym | CSF3; G-CSF; Granulocyte Colony Stimulating Factor; Pluripoietin; Filgrastim; Lenograstim |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 15.6-1000pg/mL |
| Sensitivity | 6pg/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human GCSF in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human GCSF. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human GCSF and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human GCSF, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human GCSF. You can calculate the concentration of Human GCSF in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human GCSF ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (pg/mL) | 50.8 | 115.18 | 351.06 | 48.95 | 114.71 | 370.62 |
| Standard deviation | 3.08 | 5.57 | 18.04 | 3.01 | 4.67 | 20.01 |
| CV(%) | 6.06 | 4.84 | 5.14 | 6.14 | 4.07 | 5.4 |
RECOVERY
The recovery of Human GCSF spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 88-103 | 94 |
| EDTA plasma (n=8) | 87-99 | 92 |
| Cell culture media (n=8) | 87-101 | 93 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human GCSF in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with CSF3 ELISA Kits
| CSF2 ELISA Kit | publications with CSF3 and CSF2 |
| CSF3R ELISA Kit | publications with CSF3 and CSF3R |
| MMP9 ELISA Kit | publications with CSF3 and MMP9 |
| IL10 ELISA Kit | publications with CSF3 and IL10 |
| CXCL12 ELISA Kit | publications with CSF3 and CXCL12 |
| SELL ELISA Kit | publications with CSF3 and SELL |
| STAT3 ELISA Kit | publications with CSF3 and STAT3 |
| CXCR4 ELISA Kit | publications with CSF3 and CXCR4 |
Pathways associated with CSF3 ELISA Kit
| Cytokine-cytokine Receptor Interaction Pathway | Cytokine-cytokine Receptor Interaction Pathway |
| Cytokines And Inflammatory Response Pathway | Cytokines And Inflammatory Response Pathway |
| Hematopoietic Cell Lineage Pathway | Hematopoietic Cell Lineage Pathway |
| Jak-STAT Signaling Pathway | Jak-STAT Signaling Pathway |
| Malaria Pathway | Malaria Pathway |
| PI3K-Akt Signaling Pathway | PI3K-Akt Signaling Pathway |
Diseases associated with CSF3 ELISA Kit
| Disease Susceptibility | publications with CSF3 and Disease Susceptibility |
| Nervous System Diseases | publications with CSF3 and Nervous System Diseases |
| Neutropenia | publications with CSF3 and Neutropenia |
| Leukopenia | publications with CSF3 and Leukopenia |
| Anemia | publications with CSF3 and Anemia |
| Leukemia, Myeloid, Acute | publications with CSF3 and Leukemia, Myeloid, Acute |
| Breast Neoplasms | publications with CSF3 and Breast Neoplasms |
| Peripheral Nervous System Diseases | publications with CSF3 and Peripheral Nervous System Diseases |
| Pulmonary Fibrosis | publications with CSF3 and Pulmonary Fibrosis |
| Brain Injuries | publications with CSF3 and Brain Injuries |
Organs/Tissues associated with CSF3 ELISA Kit
| Skin | publications with CSF3 and Skin |
| Lung | publications with CSF3 and Lung |
| Muscle | publications with CSF3 and Muscle |
| Liver | publications with CSF3 and Liver |
| Brain | publications with CSF3 and Brain |
| Uterus | publications with CSF3 and Uterus |
| Uncharacterized Tissue | publications with CSF3 and Uncharacterized Tissue |